Comparing Arcalyst vs Kineret
| Arcalyst (rilonacept) | Kineret (anakinra) |
|
|---|
| Arcalyst (rilonacept) | Kineret (anakinra) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Pericarditis, Familial Cold Autoinflammatory Syndrome, Cryopyrin-Associated Periodic Syndromes, Muckle Wells Syndrome, Interleukin-1 Receptor Antagonist Deficiency. Arcalyst may also... View more |
Prescription only
Prescribed for Cryopyrin-Associated Periodic Syndromes, Rheumatoid Arthritis, COVID-19, Interleukin-1 Receptor Antagonist Deficiency. Kineret may also be used for purposes not listed in this medication guide. View more |
Related suggestions Cryopyrin-Associated Periodic Syndromes
Interleukin-1 Receptor Antagonist Deficiency
|
|||||||||||||||
| More about Arcalyst (rilonacept) | More about Kineret (anakinra) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Arcalyst has an average rating of 10.0 out of 10 from a total of 6 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Kineret has an average rating of 9.0 out of 10 from a total of 10 ratings on Drugs.com. 90% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Arcalyst side effects |
View all Kineret side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Arcalyst prices |
View all Kineret prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
N/A |
6 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 520 drugs are known to interact with Arcalyst:
|
A total of 521 drugs are known to interact with Kineret:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
February 27, 2008 |
November 14, 2001 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.